Napp Pharmaceuticals Limited
Usha Bradford has been working at Napp Pharmaceuticals Limited since September 2001, holding positions such as Principal Analyst, Senior Stability Analyst, and Compliance Officer. Usha also had secondments at BARD Pharmaceuticals Limited and Mundipharma Research Limited. Usha studied Pharmaceutical & Cosmetic Sciences at De Montfort University and obtained a NEBOSH General Certificate from RRC.
This person is not in any teams
Napp Pharmaceuticals Limited
Napp Pharmaceuticals is a member of the Mundipharma network of independent associated companies. Mundipharma is a global (ex-US) network of independent associated companies that research, develop and manufacture innovative pharmaceutical medicines and consumer healthcare products. We are an agile and fast-paced company seeking to increase access to health care through programmes and effective partnerships. We are forward-looking and dedicated to bringing innovative treatments to many of the world’s most challenging conditions and diseases including: Pain Management & Supportive Care, Consumer Health, Anti-Infectives, Biosimilars, CNS, Diabetes, Oncology, Ophthalmology, Respiratory and transplantation immunity. We make a difference to patient lives by delivering value to healthcare professionals in 120+ countries across Africa, Asia Pacific, Canada, Europe, Latin America and the Middle East. Our guiding principles, centred around Integrity and Patient-Centricity, are at the heart of everything we do. We encourage our people to think differently and our inclusive culture of continuous learning and collaboration make Mundipharma a great place to work.